Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.tmaid.2020.101623 http://scihub22266oqcxt.onion/10.1016/j.tmaid.2020.101623 32179124!7102608!32179124     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Travel+Med+Infect+Dis 2020 ; 34 (ä): 101623 Nephropedia Template TP {{tp|p=32179124|t=2020. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis |pdf=|usr=}}{{32179124}} gab.com Text Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis JO: Travel Med Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32179124 #FOAvip INTRODUCTION: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date. METHODS: We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI). RESULTS: 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5-92.9%), cough (57.6%, 95%CI 40.8-74.4%) and dyspnea (45.6%, 95%CI 10.9-80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0-30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7-51.8), 6.2% (95%CI 3.1-9.3) with shock. Some 13.9% (95%CI 6.2-21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR). CONCLUSION: COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19. Twit Text FOAVip Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis ????Travel Med Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32179124 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32179124 #FOAvip English Wikipedia <ref>{{Cite pmid|32179124}}</ref> Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis #MMPMID32179124 Rodriguez-Morales AJ; Cardona-Ospina JA; Gutierrez-Ocampo E; Villamizar-Pena R; Holguin-Rivera Y; Escalera-Antezana JP; Alvarado-Arnez LE; Bonilla-Aldana DK; Franco-Paredes C; Henao-Martinez AF; Paniz-Mondolfi A; Lagos-Grisales GJ; Ramirez-Vallejo E; Suarez JA; Zambrano LI; Villamil-Gomez WE; Balbin-Ramon GJ; Rabaan AA; Harapan H; Dhama K; Nishiura H; Kataoka H; Ahmad T; Sah R Travel Med Infect Dis 2020[Mar]; 34 (ä): 101623 PMID32179124show ga INTRODUCTION: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date. METHODS: We performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI). RESULTS: 660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5-92.9%), cough (57.6%, 95%CI 40.8-74.4%) and dyspnea (45.6%, 95%CI 10.9-80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0-30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7-51.8), 6.2% (95%CI 3.1-9.3) with shock. Some 13.9% (95%CI 6.2-21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR). CONCLUSION: COVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis/pathology[MESH] |Cough/virology[MESH] |Fever/virology[MESH] |Hospitalization[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis/pathology[MESH] |Respiratory Distress Syndrome/virology[MESH]Clinical, laboratory and imaging features of COVID-19: A systematic re(epmc).pdf DeepDyve Pubget Overpricing